Abstract
This paper briefly reviews the history of good laboratory practice (GLP) in Japan. It then covers results of questionnaires on why pharmaceutical companies use contract laboratories to conduct studies, and why they choose domestic over foreign laboratories. GLP standards related to contract studies are outlined. Sponsor inspections are described, including those at Taiho Pharmaceutical Co., Ltd. The quality of in-house studies versus those contracted out is examined.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
